Bio Medica Laboratories Limited (NSE: BMLL) is an Indore, Madhya Pradesh-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹188 Cr, it ranks #2,701 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 26 in Pharmaceutical Contract Manufacturing Services. The share price was ₹147.50 as of 16 Nov 2026.
| Current Price | ₹147.50 |
|---|---|
| Market Cap | ₹188 Cr |
| NSE Symbol | BMLL |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 11.5 |
| Return on Equity | 44.44% |
| Return on Assets | 21.02% |
| Beta (1Y) | 0.64 |
| Headquarters | Indore, Madhya Pradesh |
| Website | biomedica.co.in |
Promoters held 67.70% of Bio Medica Laboratories Limited's shares as of Sept 2026, unchanged from May 2026.
Bio Medica Laboratories Limited engages in manufacturing pharmaceutical parenteral formulations in India. It manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs in the form of injectables namely Liquid Injections and dry powder injections. It provides human injectables, export of injectables, veterinary injectables, contract manufacturing, quality assurance, and research and development services. The company caters to human and veterinary needs. The company was formerly known as Bio Medica Laboratories Private Limited and changed its name to Bio Medica Laboratories Limited in October 2024. Bio Medica Laboratories Limited was founded in 1988 and is based in Indore, India.
1. Pharmaceuticals-This segment engages in the manufacturing of pharmaceutical parenteral formulations. It offers various products, comprising ethical drugs, generic drugs, and over the-counter drugs in the form of injectables. 2. NA-NA 3. NA-NA 4. NA-NA
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Bio Medica Laboratories Limited | ₹188 Cr | 11.5 | 44.44% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Bio Medica Laboratories Limited is trading at ₹147.50, with a market capitalisation of ₹188 Cr.
Bio Medica Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Bio Medica Laboratories Limited has a P/E of 11.5 and a return on equity of 44.44%.
Bio Medica Laboratories Limited is listed on the NSE under the symbol BMLL.
Promoters held 67.70% of Bio Medica Laboratories Limited's shares as of Sept 2026, unchanged from May 2026.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.